The latest update is out from China Resources Pharmaceutical Group Ltd. ( (HK:3320) ).
China Resources Pharmaceutical Group Ltd. has announced a final cash dividend of RMB 0.052 per share for the financial year ending December 31, 2024, with an option for shareholders to receive the dividend in Hong Kong dollars at HKD 0.056 per share. This announcement reflects the company’s stable financial performance and commitment to delivering shareholder value, potentially enhancing its market position and investor confidence.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. operates within the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is known for its comprehensive range of products and services, catering to various market needs within the healthcare sector.
YTD Price Performance: -5.15%
Average Trading Volume: 2,135
Technical Sentiment Signal: Sell
Current Market Cap: €4.13B
Find detailed analytics on 3320 stock on TipRanks’ Stock Analysis page.